Mersana Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MRSN and other ETFs, options, and stocks.

About MRSN

Mersana Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of antibody-drug conjugates that offer clinical benefit for cancer patients. Its product candidates are Upifitamab Rilsodotin (UpRi), XMT-1536, and XMT-1592.

CEO

Martin H. Huber

CEOMartin H. Huber

Employees

123

Employees123

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

2001

Founded2001

Employees

123

Employees123

MRSN Key Statistics

Market cap

423.37M

Market cap423.37M

Price-Earnings ratio

-2.31

Price-Earnings ratio-2.31

Dividend yield

—

Dividend yield—

Average volume

1.74M

Average volume1.74M

High today

$3.63

High today$3.63

Low today

$3.42

Low today$3.42

Open price

$3.52

Open price$3.52

Volume

1.19M

Volume1.19M

52 Week high

$9.62

52 Week high$9.62

52 Week low

$0.8014

52 Week low$0.8014

Analyst ratings

78%

of 9 ratings

Buy

77.8%

Hold

22.2%

Sell